Icon

ALTOPREV (nda021316)- (10MG,20MG,40MG,60MG)

LOVASTATIN COVIS
10MG,20MG,40MG,60MG
No Yes
2018-Mar-23 Expired
None None
None No
ALTOPREV is indicated to slow the progression of coronary atherosclerosis in patients with coronary heart disease as part of a treatment strategy to lower Total-C and LDL-C to target levels. ALTOPREV is indicated as an adjunct to diet for the reduction of elevated Total-C, LDL-C, Apo B, and TG, and to increase HDL-C in patients with primary hypercholesterolemia (heterozygous familial and non-familial) and mixed dyslipidemia (Fredrickson types IIa and IIb) when the response to diet restricted in saturated fat and cholesterol and to other non-pharmacological measures alone has been inadequate.
0 0 0
Total Other Developers 3
Drugs with Suitability No
10MG ** ** - - -
20MG ** ** - - -
40MG ** ** - - -
60MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.